ARTI-CELL FORTE: new product
Saturday 01 October 2022Boehringer Ingelheim presents a new product, Arti-Cell Forte, the first stem cell-based veterinary treatment registered by the Spanish Medicines Agency.
Arti-Cell Forte is a revolutionary innovation for the equine market that is indicated for the reduction of mild to moderate recurrent lameness associated with joint inflammation in horses. It is based on stem cells, previously specifically sensitized, from peripheral blood from donor horses.
Arti-Cell Forte treats the cause and not just the symptoms of the disease:
Arti-Cell Forte is a revolutionary innovation for the equine market that is indicated for the reduction of mild to moderate recurrent lameness associated with joint inflammation in horses. It is based on stem cells, previously specifically sensitized, from peripheral blood from donor horses.
Arti-Cell Forte treats the cause and not just the symptoms of the disease:
1. Stimulates healing cartilage.
2. Reduces inflammation.
3. Long-term results with a single treatment.
Permanent results up to 1 year after a single treatment!
For more information on the proven benefits of lameness treatment with ARTI-CELL FORTE, contact us.
